Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cincinnati, Ohio


Purpose:

The purposes of this study are to determine: - The safety of duloxetine and any side effects that might be associated with it. - How duloxetine compares to escitalopram and placebo (an inactive ingredient)


Study summary:

duloxetine 60mg - 120mg, escitalopram 10mg - 20mg, and placebo, 8-month,


Criteria:

Inclusion Criteria: - Must be at least 18 of age - Must meet the criteria for major depressive disorder - You must be able to visit the doctor's office about once a week for 2 to 3 months. After that, you will need to visit the doctor's office once a month for about 6 months - You must be able to take the study drug as prescribed (6 capsules per day taken once-daily) Exclusion Criteria: - You are a woman and are pregnant or breastfeeding. - You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder. - You have a history of alcohol or drug dependence within the past 6 months


NCT ID:

NCT00073411


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

Cincinnati, Ohio
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.